5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity.
Saved in:
| Title: | 5-(Benzofuran-2-yl)-3-(2-chloro-4-fluorobenzyl)-1,3,4-oxadiazol-2(3H)-one (GM-90663) Alleviates Dravet Syndrome via Inhibiting Monoamine Oxidase Activity. |
|---|---|
| Authors: | Hwang KS; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea., Ahn SH; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea., Son Y; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea., Kim SS; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea., Shin DS; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea., Yang JY; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea., Chae CH; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea., Nakamura M; Department of Pharmacology, School of Dentistry, Kyungpook National University, Daegu 41940, Republic of Korea.; Brain Science & Engineering Institute, Kyungpook National University, Daegu 41940, Republic of Korea., Jang IS; Department of Pharmacology, School of Dentistry, Kyungpook National University, Daegu 41940, Republic of Korea.; Brain Science & Engineering Institute, Kyungpook National University, Daegu 41940, Republic of Korea., Kim G; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.; Department of Medical Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, Republic of Korea., Kim DG; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea., Kim P; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea., Heo Y; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea., Bae S; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea., Lee H; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea., Ahn JH; Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.; JD Bioscience Inc., 208 Cheomdan-dwagiro, Buk-gu, Gwangju 61011, Republic of Korea., Bae MA; Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.; Department of Medical Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, Republic of Korea. |
| Source: | Molecules (Basel, Switzerland) [Molecules] 2026 May 01; Vol. 31 (9). Date of Electronic Publication: 2026 May 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1420-3049 |
|---|---|
| DOI: | 10.3390/molecules31091511 |
